Global Biologics, LLC is privately held and operating in the Contract Research Market. For over six years our goal has been to offer steady and innovative molecular support to researchers utilizing novel yet rapidly changing genomics technologies in their research.
Our mission is to bring high value services and innovative molecular genomic and NGS service solutions to the research and biologic’s markets. Fueled by a passion for generating high value datasets, we believe that building a great scientific organization starts with meaningful services and trustworthy relationships with our clients, staff, business partners, suppliers and the broader scientific community. Our mission is always to ‘do great science.’
- Invest in people and technology to bring premier service solutions to the biotech, research and biologics markets.
- Work with local investors who can be supportive of our role in serving the community and building a long lasting profitable business.
- Focus on and leverage relationships with key partners and institutions which result in all parties benefiting from doing business together.
Partnerships And Technology:
GB leverages partnerships with institutions (govt, academic, non-profit and private), consumables companies, and essential hardware providers to perform molecular genomics and next generation sequencing services. Our goal is to offer our clients advanced solutions at the lowest possible cost. We also proactively test new solutions on the market which maintain and enhance the utility of various sequencing applications for our Customers. We utilize molecular products from all the major vendors and work with other service facilities to add capability and redundancy to our workflows. All our molecular applications are sequence validated and new methods receive benchmark testing prior to production. Finally, in 2015 GB launched a unique automation pipeline for molecular preparations which has been in development for some time. We call the system TTPS and it offers us advanced molecular preparation capabilities in terms of scale, efficiency (gains), and prevention of contamination across a variety of applications as compared to classic pipetting technologies. The system is not a micro-fluidics platform similar to existing technologies, which require extensive reagent reformulation and hardware for deployment. The system does, however, offer similar benefits in a modular format with applicability across a variety of processes.
We are currently seeking large scale research/service partnerships. Please contact us to learn more.
We’re growing and always looking to add to our front office and service lab team. If you have experience in molecular genomics, sequencing, in the life science, AgBio, or pharmaceutical sectors and are seeking employment at a professional, fun, and fast paced (high tech) environment, we want to hear from you. Send resumes and job inquiries to email@example.com. All inquiries are confidential. Global Biologics,LLC is an EEO.